GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (NYSE:WAT) » Definitions » EPS without NRI

Waters (Waters) EPS without NRI : $10.82 (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Waters EPS without NRI?

Waters's earnings per share without non-recurring items for the three months ended in Dec. 2023 was $3.62. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was $10.82.

During the past 12 months, Waters's average earnings per share (NRI) Growth Rate was -1.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 11.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 10.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Waters's EPS without NRI or its related term are showing as below:

WAT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -58.6   Med: 12.9   Max: 510.9
Current: 11.5

During the past 13 years, Waters's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 510.90% per year. The lowest was -58.60% per year. And the median was 12.90% per year.

WAT's 3-Year EPS without NRI Growth Rate is ranked better than
64.37% of 174 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.25 vs WAT: 11.50

Waters's EPS (Diluted) for the three months ended in Dec. 2023 was $3.65. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $10.85.

Waters's EPS (Basic) for the three months ended in Dec. 2023 was $3.66. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $10.89.


Waters EPS without NRI Historical Data

The historical data trend for Waters's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters EPS without NRI Chart

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.69 8.47 11.24 11.87 11.75

Waters Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.84 2.38 2.55 2.27 3.62

Competitive Comparison of Waters's EPS without NRI

For the Diagnostics & Research subindustry, Waters's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waters's PE Ratio without NRI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Waters's PE Ratio without NRI falls into.



Waters EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters  (NYSE:WAT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Waters EPS without NRI Related Terms

Thank you for viewing the detailed overview of Waters's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters (Waters) Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.
Executives
Christopher A Kuebler director 210 CARNEGIE CENTER, PRINCETON NJ 08540
Richard H Fearon director 1239 GERBING ROAD, AMELIA ISLAND FL 32034
Edward Conard director
Daniel J. Brennan director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Mark P Vergnano director 1007 MARKET STREET, WILMINGTON DE 19898
Gary E Hendrickson director 1101 THIRD STREET SOUTH, MINNEAPOLIS MN 55415
John M Ballbach director
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Michael J Berendt director
Thomas P Salice director
Wei Jiang director 34 MAPLE STREET, MILFORD MA 01757
Amol Chaubal officer: SVP and Chief Financial Office 113 HARTWELL AVE, C/O QUANTERIX CORPORATION, LEXINGTON MA 02421
Jianqing Bennett officer: SVP TA Instruments Division 34 MAPLE STREET, MILFORD MA 01757
Joann A Reed director C/O AMERICAN TOWER CORP, 116 HUNTINGTON AVENUE, BOSTON MA 02116
Belinda Hyde officer: SVP, Global Human Resources 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277

Waters (Waters) Headlines

From GuruFocus

Q2 2023 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Waters Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Waters Corp at Cowen Health Care Conference Transcript

By GuruFocus Research 01-23-2024

Q4 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024